Clinical Insights

Taylor Crews, PMHNP-BC, explores how clinicians can navigate conversations with patients who suspect they may have attention-deficit/hyperactivity disorder (ADHD) based on information from social media.

Kevin Williams, MS, MPAS, PA-C, walks clinicians through his patient-centered approach to finding the most appropriate adjunctive treatment option for major depressive disorder.

Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.

Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discusses how clinicians can support patients through the early stages of treatment for major depressive disorder.

Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares several communication strategies to effectively address patient concerns when considering augmentation for major depressive disorder (MDD).

Psych Congress NP Institute Co-Chair Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, FAAN, explains key differences in stimulant and non-stimulant treatment options for ADHD.

Julie Carbray, PhD, PMHNP-BC, APRN, discusses how emerging therapies for bipolar disorder differ from traditional mood stabilizers, including improved tolerability and reduced side effects.

Julie Carbray, PhD, PMHNP-BC, APRN, provides an overview of some of the key cardiometabolic symptoms and adverse effects that clinicians should be on the lookout for in their patients with bipolar disorder.

Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...

Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.